1. Fat necrosis of the breast in the accelerated partial breast irradiation era: the need for a universal grading system

   • Andrea L. Russo
   • Alphonse G. Taghian

   Review 25 June 2013 Pages: 1 - 11

   

2. Myeloid-derived suppressor cells in breast cancer

   • Joseph Markowitz
   • Robert Wesolowski
   • William E. Carson III

   Review 05 July 2013 Pages: 13 - 21

3. Inflammatory breast cancer (IBC): clues for targeted therapies

   • Sandra V. Fernandez
   • Fredika M. Robertson
   • Massimo Cristofanilli

   Preclinical study Open access 21 June 2013 Pages: 23 - 33

   

4. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells

   • Tatjana Kaiser
   • Ingrid Teufel
   • Tanja Fehm

   Preclinical Study 27 June 2013 Pages: 35 - 48

   

5. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer

   • Yunli Zhou
   • Lili Zhao
   • Zhi Yao

   Preclinical study 27 June 2013 Pages: 49 - 61

   

6. Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

   • E. H. Lips
   • L. Mulder
   • J. Wesseling

   Preclinical Study Open access 05 July 2013 Pages: 63 - 71

   

7. A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer

   • R. Charles Coombes
   • Fatima Cardoso
   • Peter Schmid

   Clinical trial 25 June 2013 Pages: 73 - 82

   

8. The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

   • Salomon M. Stemmer
   • Shmuel H. Klang
   • Nicky Lieberman

   Clinical Trial Open access 26 June 2013 Pages: 83 - 92

   

9. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years’ follow-up

   • Anna-Karin Falck
   • Pär-Ola Bendahl
   • Lisa Rydén

   Clinical Trial 27 June 2013 Pages: 93 - 104

   

10. Cording following treatment for breast cancer

    • Jean O’Toole
    • Cynthia L. Miller
    • Alphonse G. Taghian

    Clinical trial 29 June 2013 Pages: 105 - 111

    

11. Ultrasound-guided fine-needle aspiration of suspicious nodes in breast cancer patients; selecting patients with extensive nodal involvement

    • B. J. van Wely
    • J. H. W. de Wilt
    • L. J. A. Strobbe

    Clinical Trial 30 June 2013 Pages: 113 - 118

    

12. Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT)

    • Rachel Y. Lei
    • Charles E. Leonard
    • Dennis L. Carter

    Clinical trial Open access 04 July 2013 Pages: 119 - 133

    

13. Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

    • D. Gareth R. Evans
    • Sarah L. Ingham
    • Anthony Howell

    Epidemiology 20 June 2013 Pages: 135 - 142

    

14. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival

    • J. P. Bulte
    • B. J. van Wely
    • J. H. W. de Wilt

    Epidemiology 23 June 2013 Pages: 143 - 149

    

15. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility

    • Jibing Liu
    • Xiaohu Tang
    • Ming Yang

    Epidemiology 23 June 2013 Pages: 151 - 157

16. Weight, inflammation, cancer-related symptoms and health-related quality of life among breast cancer survivors

    • Ikuyo Imayama
    • Catherine M. Alfano
    • Anne McTiernan

    Epidemiology 25 June 2013 Pages: 159 - 176

    

17. Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa

    • Herbert Cubasch
    • Maureen Joffe
    • Judith S. Jacobson

    Epidemiology Open access 26 June 2013 Pages: 177 - 186

    

18. Providing access to risk prediction tools via the HL7 XML-formatted risk web service

    • Jonathan Chipman
    • Brian Drohan
    • Phil Bosinoff

    Brief Report 23 June 2013 Pages: 187 - 193

    

19. Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers

    • Anita Bane
    • Alicia Viloria-Petit
    • Irene L. Andrulis

    Brief Report Open access 28 June 2013 Pages: 195 - 205

    

20. Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations

    • Luna Kadouri
    • Michal Sagi
    • Tamar Peretz

    Brief Report 04 July 2013 Pages: 207 - 211